Organization

Zhejiang University Medical School Attached First Hospital

1 abstract

Abstract
OriCAR-017, a novel GPRC5D-targeting CAR-T, in patients with relapsed/refractory multiple myeloma: Long term follow-up results of phase 1 study (POLARIS).
Org: Zhejiang University Medical School Attached First Hospital, Department of Hematology, The First Affiliated Hospital, Zhejiang University, Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine,